Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Davies, Andrew"" wg kryterium: Autor


Tytuł :
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)
Autorzy :
Gibb, Adam
Pirrie, Sarah J.
Linton, Kim
Warbey, Victoria
Paterson, Kathryn
Davies, Andrew J.
Collins, Graham P.
Menne, Tobias
McKay, Pamela
Fields, Paul A.
Miall, Fiona M.
Nagy, Eszter
Wheatley, Keith
Reed, Rachel
Baricevic‐Jones, Ivona
Barrington, Sally
Radford, John
Pokaż więcej
Temat :
HODGKIN'S disease
COMPUTED tomography
POSITRON emission tomography
OLDER patients
DRUG efficacy
Źródło :
British Journal of Haematology; Apr2021, Vol. 193 Issue 1, p63-71, 9p
Czasopismo naukowe
Tytuł :
Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance.
Autorzy :
Ahmed, Sophia
Glover, Paul
Taylor, Jan
Sha, Chulin
Care, Matthew A.
Tooze, Reuben
Davies, Andrew
Westhead, David R.
Johnson, Peter W. M.
Burton, Catherine
Barrans, Sharon L.
Pokaż więcej
Temat :
GENE expression
GENE expression profiling
LYMPHOMAS
B cells
COMPARATIVE studies
Źródło :
British Journal of Haematology; Feb2021, Vol. 192 Issue 3, p599-604, 6p
Czasopismo naukowe
Tytuł :
short report Reliable detection of clonal IgH/Bcl2 MBR rearrangement in follicular lymphoma: methodology and clinical significance.
Autorzy :
Iqbal, Sameena
Jenner, Michael J.R.
Summers, Karin E.
Davies, Andrew J.
Matthews, Janet
Norton, Andrew J.
Calaminici, Maria
Rohatiner, Ama Z.
Fitzgibbon, Jude
Lister, T. Andrew
Goff, Lindsey K.
Pokaż więcej
Temat :
LYMPHOMAS
MEDICAL genetics
DIAGNOSIS
LYMPHOID tissue
POLYMERASE chain reaction
GENETICS
Źródło :
British Journal of Haematology; Feb2004, Vol. 124 Issue 3, p325-328, 4p
Czasopismo naukowe
Tytuł :
The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real-time polymerase chain reaction.
Autorzy :
Summers, Karin E.
Davies, Andrew J.
Matthews, Janet
Jenner, Michael J.
Cornelius, Victoria
Amess, John A.
Norton, Andrew J.
Rohatiner, Ama Z. S.
Fitzgibbon, Jude
Lister, T. Andrew
Goff, Lindsey K.
Pokaż więcej
Temat :
LYMPHOMAS
PERIPHERAL circulation
BONE marrow
POLYMERASE chain reaction
Źródło :
British Journal of Haematology; Aug2002, Vol. 118 Issue 2, p563-566, 4p
Czasopismo naukowe
Tytuł :
The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper.
Autorzy :
Cwynarski K; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Marzolini MAV; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Barrington SF; King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK.
Follows G; Department of Haematology, Addenbrooke's Hospital, Cambridge, UK.
Illidge T; Department of Clinical Oncology, Christie Hospital, Manchester, UK.
Stern S; Department of Haematology, St Helier Hospital, Carshalton, UK.
Davies A; Department of Medical Oncology, Southampton General Hospital, Southampton, UK.
Pokaż więcej
Corporate Authors :
British Society for Haematology Guidelines
Źródło :
British journal of haematology [Br J Haematol] 2019 May; Vol. 185 (3), pp. 402-409. Date of Electronic Publication: 2019 Jan 04.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphoma, B-Cell*/diagnostic imaging
Lymphoma, B-Cell*/therapy
Mediastinal Neoplasms*/diagnostic imaging
Mediastinal Neoplasms*/therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biopsy ; Chemoradiotherapy ; Clinical Trials as Topic ; Combined Modality Therapy ; Female ; Hematopoietic Stem Cell Transplantation ; Humans ; Immunotherapy ; Infertility/chemically induced ; Male ; Positron Emission Tomography Computed Tomography ; Pregnancy ; Pregnancy Complications, Neoplastic/drug therapy ; Pregnancy, High-Risk ; Recurrence ; Salvage Therapy ; Thrombophilia/drug therapy ; Thrombophilia/etiology
Czasopismo naukowe
Tytuł :
Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma.
Autorzy :
Fox CP; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Phillips EH; Department of Haematology, University College Hospital, London, UK.
Smith J; Department of Haematology, Division of Cancer Sciences, School of Medical Sciences, Aintree Hospital NHS Trust, Liverpool, UK.
Linton K; University of Manchester, Manchester, UK.
Gallop-Evans E; Velindre Cancer Centre, Cardiff, UK.
Hemmaway C; Department of Haematology, Barking, Havering and Redbridge University Hospitals, Essex, UK.
Auer DP; Division of Clinical Neuroscience, Radiological Sciences, University of Nottingham, Nottingham, UK.
Fuller C; Department of Neuropsychology, Barking, Havering and Redbridge University Hospitals, Essex, UK.
Davies AJ; Department of Medical Oncology, Southampton General Hospital, Southampton, UK.
McKay P; Department of Haematology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Cwynarski K; Department of Haematology, University College Hospital, London, UK.
Pokaż więcej
Corporate Authors :
British Society for Haematology
Źródło :
British journal of haematology [Br J Haematol] 2019 Feb; Vol. 184 (3), pp. 348-363. Date of Electronic Publication: 2018 Nov 23.
Typ publikacji :
Journal Article; Practice Guideline; Systematic Review
MeSH Terms :
Central Nervous System Neoplasms/*diagnosis
Central Nervous System Neoplasms/*therapy
Lymphoma, Large B-Cell, Diffuse/*diagnosis
Lymphoma, Large B-Cell, Diffuse/*therapy
Humans
Czasopismo naukowe
Tytuł :
Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study.
Autorzy :
Illidge TM; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK.
McKenzie HS; NIHR/Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK.
Mayes S; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK.
Bates A; NIHR/Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK.
Davies AJ; NIHR/Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK.
Pettengell R; Department of Haematology, St Georges University of London, London, UK.
Stanton L; Southampton Clinical Trials Unit, Southampton, UK.
Cozens K; Southampton Clinical Trials Unit, Southampton, UK.
Hampson G; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
Dive C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
Zivanovic M; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK.
Tipping J; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK.
Gallop-Evans E; Clinical Trials Unit, Velindre Cancer Centre, Cardiff, UK.
Radford JA; Manchester Academic Health Sciences Centre, University of Manchester, Christie NHS Foundation Trust, Manchester, UK.
Johnson PW; NIHR/Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2016 Apr; Vol. 173 (2), pp. 274-82. Date of Electronic Publication: 2016 Feb 05.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Immunotherapy/*methods
Lymphoma, Follicular/*therapy
Neoplasm Recurrence, Local/*therapy
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Murine-Derived/administration & dosage ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Doxorubicin/administration & dosage ; Doxorubicin/adverse effects ; Female ; Humans ; Immunotherapy/adverse effects ; Male ; Middle Aged ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Prospective Studies ; Radioimmunotherapy/adverse effects ; Radioimmunotherapy/methods ; Radiopharmaceuticals/administration & dosage ; Radiopharmaceuticals/adverse effects ; Rituximab/pharmacokinetics ; Treatment Outcome ; Vincristine/administration & dosage ; Vincristine/adverse effects
Czasopismo naukowe
Tytuł :
A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma.
Autorzy :
Coiffier B; Service d'Hematologie, Hospices Civils de Lyon, Lyon, France.
Radford J
Bosly A
Martinelli G
Verhoef G
Barca G
Davies A
Decaudin D
Gallop-Evans E
Padmanabhan-Iyer S
Van Eygen K
Wu KL
Gupta IV
Lin TS
Goldstein N
Jewell RC
Winter P
Lisby S
Pokaż więcej
Corporate Authors :
415 study investigators
Źródło :
British journal of haematology [Br J Haematol] 2013 Nov; Vol. 163 (3), pp. 334-42. Date of Electronic Publication: 2013 Aug 23.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunotherapy*/adverse effects
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Agents/*therapeutic use
Lymphoma, Large B-Cell, Diffuse/*therapy
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/pharmacokinetics ; Antibodies, Monoclonal, Humanized ; Antibodies, Monoclonal, Murine-Derived/administration & dosage ; Antigens, CD20/immunology ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Antineoplastic Agents, Alkylating/administration & dosage ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Combined Modality Therapy ; Disease-Free Survival ; Drug Resistance, Neoplasm ; Female ; Hematologic Diseases/chemically induced ; Hematopoietic Stem Cell Transplantation ; Humans ; Kaplan-Meier Estimate ; Lymphoma, Large B-Cell, Diffuse/surgery ; Male ; Middle Aged ; Recurrence ; Remission Induction ; Rituximab ; Salvage Therapy ; Young Adult
Czasopismo naukowe
Tytuł :
Use of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization: an analysis of mobilization and engraftment.
Autorzy :
Publicover A; Wessex Blood and Marrow Transplantation Unit, Department of Haematology, University Hospital Southampton, Southampton, UK. />Richardson DS
Davies A
Hill KS
Hurlock C
Hutchins D
Jenner MW
Johnson PW
Lamb J
Launders H
McKeag N
Newman J
Orchard KH
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2013 Jul; Vol. 162 (1), pp. 107-11. Date of Electronic Publication: 2013 Apr 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Mobilization*/methods
Peripheral Blood Stem Cell Transplantation*
Biosimilar Pharmaceuticals/*pharmacology
Granulocyte Colony-Stimulating Factor/*pharmacology
Hematopoietic Stem Cells/*cytology
Hematopoietic Stem Cells/*drug effects
Adolescent ; Adult ; Aged ; Antigens, CD34/metabolism ; European Union ; Female ; Graft Survival/drug effects ; Hematopoietic Stem Cells/metabolism ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Transplantation, Autologous ; Young Adult
Czasopismo naukowe
Tytuł :
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.
Autorzy :
Davies AJ; Cancer Research UK Medical Oncology Unit, St Bartholomew's Hospital, London, UK. andrew.davies@cancer.org.uk
Rosenwald A
Wright G
Lee A
Last KW
Weisenburger DD
Chan WC
Delabie J
Braziel RM
Campo E
Gascoyne RD
Jaffe ES
Muller-Hermelink K
Ott G
Calaminici M
Norton AJ
Goff LK
Fitzgibbon J
Staudt LM
Andrew Lister T
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2007 Jan; Vol. 136 (2), pp. 286-93.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Transformation, Neoplastic*
Gene Expression Profiling*
Oligonucleotide Array Sequence Analysis*
Lymphoma, Follicular/*pathology
Lymphoma, Large B-Cell, Diffuse/*pathology
Cell Proliferation ; Disease Progression ; Genes, myc ; Humans ; Lymphoma, Follicular/genetics ; Lymphoma, Large B-Cell, Diffuse/genetics ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies